Skip to main content

Complex of IgE and Ligelizumab


Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
De6uqrD1 A: alpha arraysX: Nat/IvyH: Acyl-CoA N-acyltransferases (Nat)T: Acyl-CoA N-acyltransferases (Nat)F:ECOD (v295.2)
Be6uqrB1 A: alpha arraysX: Nat/IvyH: Acyl-CoA N-acyltransferases (Nat)T: Acyl-CoA N-acyltransferases (Nat)F:ECOD (v295.2)
Ce6uqrC1 A: alpha arraysX: Nat/IvyH: Acyl-CoA N-acyltransferases (Nat)T: Acyl-CoA N-acyltransferases (Nat)F:ECOD (v295.2)
Ae6uqrA1 A: alpha arraysX: Nat/IvyH: Acyl-CoA N-acyltransferases (Nat)T: Acyl-CoA N-acyltransferases (Nat)F:ECOD (v295.2)

Domain Annotation: CATH CATH Database Homepage

ChainDomainClassArchitectureTopologyHomologyProvenance Source (Version)
D2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (utative)
B2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (utative)
A2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (utative)

IMGT Antibody Annotation IMGT Database Homepage

ChainProtein NameDescriptionOrganism NameGene Allele Name(s)Domain Name(s)Receptor TypeReceptor DescriptionProvenance Source
A, C
Fab Ligelizumab, anti-Fc-epsilon (IGHE) SCFV-HEAVY-KAPPA Homo sapiens (human) IGHV1-69*01, IGHV1-69*06, IGHV1-69*08, IGHV1-69*11, IGHV1-69*12, IGHV1-69*13, IGHV1-69*14, IGHV1-69D*01, IGHV1-69*15, IGHJ4*01, IGHJ4*02, IGHJ4*03, IGKV3-15*01, IGKV3D-15*01, IGKJ4*01, IGKJ4*02 V-DOMAIN VH, V-DOMAIN V-KAPPA IG SCFV-HEAVY-KAPPA IMGT (202638-0)

Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage

ChainNameTargetProvenance Source
A, C
Ligelizumab IGHETherapeutic SAbDab (2026-10-02)

Protein Family Annotation Pfam Database Homepage

ChainsAccessionNameDescriptionCommentsSource
B, D
PF07654Immunoglobulin C1-set domain (C1-set)Immunoglobulin C1-set domainDomain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

ChainsPolymerMolecular FunctionBiological ProcessCellular Component
B, D
IgE
A, C
Ligelizumab---

Pharos: Disease Associations Pharos Homepage Annotation